Table 3:
Pre-Transplant Characteristics of the Propensity Matched Cohort.
| Variable |
Overall (n=5486) |
Bridge to Transplant (n=2743) |
Medical Management (n=2743) |
p-value | ASD Prior to PSM (%) | ASD After PSM (%) |
|---|---|---|---|---|---|---|
| Age (years) | 54.0 ± 12.1 | 54.0 ± 12.1 | 54.1 ± 12.1 | 0.628 | 1.0 | 1.3 |
| Male Gender, n(%) | 4239 (77.3) | 2105 (76.7) | 2134 (77.8) | 0.350 | 25.3 | 2.5 |
| Ethnicity | 0.999 | 4.8 | 0.2 | |||
| White | 3754 (68.4) | 1877 (68.4) | 1877 (68.4) | |||
| African American | 1146 (20.9) | 572 (20.9) | 574 (20.9) | |||
| Hispanic | 365 (6.7) | 183 (6.7) | 182 (6.6) | |||
| Other | 221 (4.0) | 111 (4.1) | 110 (4.0) | |||
| Diabetes, n(%) | 1613 (29.5) | 820 (30.0) | 793 (29.0) | 0.423 | 11.4 | 2.2 |
| CVA, n(%) | 304 (5.6) | 175 (6.4) | 129 (4.7) | 0.006 | 1.8 | 7.4 |
| Smoking, n(%) | 2834 (51.7) | 1421 (51.8) | 1413 (51.2) | 0.829 | 19.1 | 0.6 |
| AICD, n(%) | 4508 (82.7) | 2221 (81.6) | 2287 (83.8) | 0.039 | 3.9 | 5.7 |
| Blood Type O, n(%) | 2137 (39.0) | 1064 (38.8) | 1073 (39.1) | 0.803 | 22.6 | 0.7 |
| BMI (kg/m2) | 27.4 ± 4.7 | 27.4 ± 4.7 | 27.4 ± 4.7 | 0.654 | 36.3 | 1.2 |
| Non-Dilated Myopathy | 173 (3.2) | 81 (3.0) | 92 (3.4) | 0.395 | 49.4 | 2.3 |
| Status @ Listing | 0.400 | 15.5 | 1.9 | |||
| Status 1A | 1443 (26.3) | 723 (26.4) | 720 (26.3) | |||
| Status 1B | 2611 (47.6) | 1284 (46.8) | 1327 (48.4) | |||
| Status 2 | 1432 (26.1) | 736 (26.8) | 696 (25.4) | |||
| Status 1A @ Transplant | 3469 (63.2) | 1736 (63.3) | 1733 (63.2) | 0.933 | 46.7 | 0.2 |
| Functional Status | 0.654 | 7.4 | 1.3 | |||
| Poor | 1598 (29.1) | 785 (28.6) | 813 (29.6) | |||
| Moderate | 3012 (54.9) | 1522 (55.5) | 1490 (54.3) | |||
| Excellent | 876 (15.9) | 436 (15.9) | 440 (16.0) | |||
| eGFR (mL/min/1.73m2) | 72.7 ± 27.8 | 72.6 ± 27.2 | 72.9 ± 28.4 | 0.701 | 9.5 | 1.0 |
| PVR (Woods Units) | 2.41 ± 1.49 | 2.39 ± 1.51 | 2.37 ± 1.50 | 0.940 | 17.2 | 1.3 |
| Wait Time > 6 Months | 1938 (35.3) | 932 (34.0) | 1006 (36.7) | 0.037 | 58.9 | 5.6 |
CVA, cerebrovascular accident; AICD, automated internal cardioverter defibrillator; BMI, body mass index; eGFR, estimated glomerular filtration rate; WL, waiting list; PA, pulmonary artery; PVR, pulmonary vascular resistance.